Mork J, Lie A K, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller J T, Youngman L, Lehtinen M, Dillner J
Cancer Registry of Norway, Oslo.
N Engl J Med. 2001 Apr 12;344(15):1125-31. doi: 10.1056/NEJM200104123441503.
Oncogenic human papillomaviruses (HPVs), especially HPV type 16 (HPV-16), cause anogenital epithelial cancers and are suspected of causing epithelial cancers of the head and neck.
To examine the relation between head and neck cancers and HPVs, we performed a nested case-control study within a joint Nordic cohort in which serum samples were collected from almost 900,000 subjects. Samples collected at enrollment from 292 persons in whom squamous-cell carcinoma of the head and neck developed, on average, 9.4 years after enrollment and from 1568 matched controls were analyzed for antibodies against HPV-16, HPV-18, HPV-33, and HPV-73 and for cotinine levels as a marker of smoking habits. Polymerase-chain-reaction (PCR) analyses for HPV DNA were performed in tumor tissue from 160 of the study patients with cancer.
After adjustment for cotinine levels, the odds ratio for squamous-cell carcinoma of the head and neck in subjects who were seropositive for HPV-16 was 2.2 (95 percent confidence interval, 1.4 to 3.4). No increased risk was observed for other HPV types. Fifty percent of oropharyngeal and 14 percent of tongue cancers contained HPV-16 DNA, according to PCR analysis.
HPV-16 infection may be a risk factor for squamous-cell carcinoma of the head and neck.
致癌性人乳头瘤病毒(HPV),尤其是16型HPV(HPV - 16),可引发肛门生殖器上皮癌,并被怀疑与头颈上皮癌的发生有关。
为研究头颈癌与HPV之间的关系,我们在一个北欧联合队列中进行了一项巢式病例对照研究,该队列收集了近90万名受试者的血清样本。对入组时收集的样本进行分析,这些样本来自292例在入组平均9.4年后发生头颈鳞状细胞癌的患者,以及1568例匹配的对照,检测其针对HPV - 16、HPV - 18、HPV - 33和HPV - 73的抗体以及作为吸烟习惯标志物的可替宁水平。对160例研究中的癌症患者的肿瘤组织进行HPV DNA的聚合酶链反应(PCR)分析。
在对可替宁水平进行校正后,HPV - 16血清学阳性受试者发生头颈鳞状细胞癌的优势比为2.2(95%置信区间为1.4至3.4)。未观察到其他HPV类型导致的风险增加。根据PCR分析,50%的口咽癌和14%的舌癌含有HPV - 16 DNA。
HPV - 16感染可能是头颈鳞状细胞癌的一个危险因素。